propadiene has been researched along with paclitaxel in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, B; Chen, Y; Gu, H; Li, S; Liang, F; Wang, H; Wang, J; Yang, G; Yang, L | 1 |
1 other study(ies) available for propadiene and paclitaxel
Article | Year |
---|---|
Analysis of the chemotherapeutic effects of a propadiene compound on malignant ovarian cancer cells.
Topics: Alkadienes; Animals; Antineoplastic Agents; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 2; Cisplatin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Inhibitory Concentration 50; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Phosphatidylinositol 3-Kinases | 2016 |